2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenanthridin-6(5H)-one

ID: ALA3259994

PubChem CID: 25132505

Max Phase: Preclinical

Molecular Formula: C16H9F6NO2

Molecular Weight: 361.24

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1[nH]c2ccc(C(O)(C(F)(F)F)C(F)(F)F)cc2c2ccccc12

Standard InChI:  InChI=1S/C16H9F6NO2/c17-15(18,19)14(25,16(20,21)22)8-5-6-12-11(7-8)9-3-1-2-4-10(9)13(24)23-12/h1-7,25H,(H,23,24)

Standard InChI Key:  NKLTUBXOEGMKJS-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   33.1155   -1.9315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1143   -2.7510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8224   -3.1600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.8206   -1.5226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5292   -1.9279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.5280   -2.7531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9551   -1.9300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2405   -1.5141    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.9539   -2.7551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2375   -3.1620    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.2326   -3.9840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9435   -4.4002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6607   -3.9883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6620   -3.1676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.6638   -1.5231    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   32.4063   -3.1591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6989   -2.7499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.9909   -3.1580    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.6996   -1.9327    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   30.9872   -2.3401    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.4056   -3.9763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.6976   -4.3843    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   33.1130   -4.3854    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   32.3987   -4.7917    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   31.6930   -3.5618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5  8  1  0
  6 10  1  0
  9  7  1  0
  7  8  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  7 15  2  0
  2 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 16 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
 16 25  1  0
M  END

Associated Targets(Human)

RORA Tchem Nuclear receptor ROR-alpha (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORB Tchem Nuclear receptor ROR-beta (600 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RORC Tchem Nuclear receptor ROR-gamma (8495 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 361.24Molecular Weight (Monoisotopic): 361.0537AlogP: 3.99#Rotatable Bonds: 1
Polar Surface Area: 53.09Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 7.38CX Basic pKa: CX LogP: 3.87CX LogD: 3.55
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.51Np Likeness Score: -0.42

References

1. Nishiyama Y, Nakamura M, Misawa T, Nakagomi M, Makishima M, Ishikawa M, Hashimoto Y..  (2014)  Structure-activity relationship-guided development of retinoic acid receptor-related orphan receptor gamma (RORγ)-selective inverse agonists with a phenanthridin-6(5H)-one skeleton from a liver X receptor ligand.,  22  (9): [PMID:24702856] [10.1016/j.bmc.2014.03.007]
2. Nishiyama Y, Mori S, Makishima M, Fujii S, Kagechika H, Hashimoto Y, Ishikawa M..  (2018)  Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.,  (7): [PMID:30034593] [10.1021/acsmedchemlett.8b00058]

Source